According to Gram Research analysis, scientists discovered that kaempferol 3,4’-diglucoside, a compound found in the edible plant Gnaphalium affine, powerfully blocks xanthine oxidase, the enzyme that creates uric acid in the body. In laboratory testing, this compound showed an inhibitory strength (IC50) of 14.1 micrometers, making it one of the most potent natural uric acid inhibitors identified to date. The plant contains 65 flavonoids total, with 56 being previously unknown to science, suggesting it could become a functional food for managing high uric acid levels and gout.
Scientists discovered that a common edible plant called Gnaphalium affine contains powerful compounds that can help lower uric acid levels in the body. Using advanced computer technology and lab testing, researchers identified 65 different flavonoids (natural plant chemicals) in this plant, with one called kaempferol 3,4’-diglucoside showing the strongest ability to block xanthine oxidase, the enzyme responsible for making uric acid. This discovery could lead to new natural treatments for people with high uric acid levels, a condition that causes gout and other health problems.
Key Statistics
A 2026 laboratory study published in Food & Function identified 65 flavonoids in Gnaphalium affine, with 56 being previously unreported in the plant species, revealing it as a rich source of uric acid-lowering compounds.
Kaempferol 3,4’-diglucoside, a compound from Gnaphalium affine, demonstrated an IC50 value of 14.1 ± 0.8 micrometers in laboratory testing, making it comparable to or more potent than many synthetic xanthine oxidase inhibitors used clinically.
Computer modeling revealed that kaempferol 3,4’-diglucoside binds to xanthine oxidase with exceptional strength (docking energy of -68.1 kcal/mol), indicating a multimodal binding mechanism enhanced by its two attached sugar molecules.
The research identified that di-glycosylation (two sugar attachments) significantly enhances flavonoid binding stability and affinity to xanthine oxidase compared to single-sugar variants, revealing new structure-activity relationships for uric acid inhibition.
The Quick Take
- What they studied: Whether compounds found in Gnaphalium affine, an edible plant, could block the enzyme that creates uric acid in the body
- Who participated: This was laboratory research testing plant compounds in test tubes and computer models, not human volunteers. Scientists analyzed 56 flavonoid compounds from the plant
- Key finding: One compound called kaempferol 3,4’-diglucoside was extremely effective at blocking the uric acid-making enzyme, with an inhibitory strength (IC50) of 14.1 micrometers, making it one of the most powerful natural inhibitors tested
- What it means for you: This plant could potentially become a natural food-based option for managing high uric acid levels and gout, though human studies are still needed to confirm it works in real people
The Research Details
Researchers used a two-step approach to find uric acid-fighting compounds in Gnaphalium affine. First, they used advanced computer technology called molecular networking to identify and map out all the different flavonoids (plant chemicals) in the plant. This technique breaks down the plant’s complex mixture into individual compounds and shows how they’re related to each other. Second, they used artificial intelligence to predict how well each compound would fit into and block the xanthine oxidase enzyme, similar to how a key fits into a lock. The most promising candidates were then tested in laboratory conditions to measure their actual ability to inhibit the enzyme. This combination of computer prediction and lab testing allowed scientists to quickly narrow down thousands of potential compounds to the most effective ones.
This research approach is important because natural plants contain hundreds or thousands of different compounds mixed together, making it nearly impossible to test each one individually. By using computer technology to predict which compounds are most likely to work before doing expensive lab tests, scientists can save time and money while discovering new treatments faster. This method could be applied to other plants and other health conditions, creating a faster pipeline for finding natural medicines.
This study used cutting-edge technology and rigorous laboratory methods to validate findings. The researchers used multiple approaches (computer modeling, molecular analysis, and lab testing) to confirm their results, which strengthens confidence in the findings. However, this was laboratory research only—the compounds were tested in test tubes and computer models, not in living animals or humans yet. The study identified 56 previously unknown flavonoids in the plant, suggesting thorough analysis. The most promising compound showed very strong binding to the target enzyme in computer models and strong inhibitory activity in lab tests.
What the Results Show
Scientists identified 65 different flavonoids in Gnaphalium affine, with 56 of these being completely new discoveries for this plant species. Among all the compounds tested, kaempferol 3,4’-diglucoside emerged as the clear winner, showing the strongest ability to block xanthine oxidase. In computer modeling, this compound fit into the enzyme’s active site with exceptional strength (docking energy of -68.1 kcal/mol, which indicates very strong binding). When tested in the laboratory, it inhibited the enzyme with an IC50 value of 14.1 micrometers, meaning this was the concentration needed to block half the enzyme’s activity. This makes it comparable to or better than many synthetic drugs currently used to treat high uric acid. The researchers discovered that the compound’s effectiveness comes from its unique structure—specifically, the two sugar molecules attached to it enhance how well it binds to and blocks the enzyme.
The study revealed important patterns about how flavonoid structure affects their ability to block uric acid production. Compounds with two sugar molecules attached (like kaempferol 3,4’-diglucoside) were significantly more effective than similar compounds with only one sugar molecule. This finding suggests that the sugar attachments aren’t just decorative—they actively improve the compound’s ability to bind to and inhibit the enzyme. The research also confirmed that Gnaphalium affine is indeed a functional food source, meaning it contains compounds with genuine health benefits beyond basic nutrition. The identification of 56 previously unknown flavonoids in this plant suggests it may have other health benefits that haven’t been discovered yet.
This research builds on decades of studies showing that flavonoids from plants can help manage uric acid levels. Previous research identified some flavonoids with uric acid-lowering properties, but this study is notable for discovering so many new compounds in a single plant and for identifying one compound that appears to be among the most potent natural xanthine oxidase inhibitors discovered to date. The combination of molecular networking and AI modeling represents a newer, faster approach compared to traditional plant screening methods. This integrated approach could accelerate the discovery of other beneficial compounds in plants that have been used in traditional medicine.
This study was conducted entirely in laboratory conditions using test tubes and computer models—it did not involve living animals or humans. Therefore, we don’t yet know if these compounds will work the same way inside the human body, where they must be absorbed through the digestive system and survive metabolism. The study tested isolated compounds rather than whole plant extracts, so the actual effectiveness of eating the plant might differ. Additionally, the research doesn’t address how much of the plant someone would need to eat to get therapeutic benefits, or whether the compounds remain stable during cooking or digestion. Long-term safety and potential side effects in humans remain unknown and would require additional research.
The Bottom Line
Based on this research, Gnaphalium affine shows strong potential as a functional food for managing uric acid levels, but it’s too early to recommend it as a treatment. People with high uric acid or gout should continue using their prescribed medications while this plant is studied further in animals and humans. If future research confirms these findings in human studies, Gnaphalium affine could become a valuable dietary addition to conventional treatments. Confidence level: Moderate for laboratory findings; Low for real-world human application until clinical trials are completed.
This research is most relevant to people with hyperuricemia (high uric acid levels) or gout, as well as researchers developing new treatments for these conditions. It’s also of interest to food scientists and nutritionists looking for functional foods with health benefits. People taking conventional uric acid-lowering medications should not replace their treatment with this plant without medical guidance. Individuals interested in plant-based wellness and traditional medicine may find this research validates some traditional uses of this plant.
If this plant extract were developed into a supplement or functional food, it would likely take 3-5 years of human clinical trials before any health claims could be made. Even then, benefits would probably develop gradually over weeks to months of consistent use, similar to other natural uric acid-lowering approaches. This is not a quick fix—it would be a long-term dietary strategy.
Frequently Asked Questions
Can I eat Gnaphalium affine to lower my uric acid levels?
While laboratory research shows the plant contains powerful uric acid-lowering compounds, human studies haven’t been conducted yet. Continue your prescribed medications and consult your doctor before adding this plant to your diet, as its real-world effectiveness in people remains unknown.
What is kaempferol 3,4’-diglucoside and why is it special?
It’s a natural plant compound found in Gnaphalium affine that blocks xanthine oxidase, the enzyme making uric acid. Laboratory tests show it’s one of the most potent natural inhibitors discovered, with strength comparable to pharmaceutical treatments, though human testing is still needed.
How many new compounds did scientists find in this plant?
Researchers identified 56 previously unknown flavonoids in Gnaphalium affine, bringing the total discovered compounds to 65. This suggests the plant may have multiple health benefits beyond uric acid management that warrant further investigation.
Is this plant safe to eat regularly?
Long-term safety data in humans doesn’t exist yet. While the plant is edible and used traditionally, consuming it as a therapeutic treatment requires clinical trials first. Consult a healthcare provider before using it as a supplement or medicine.
When will this become available as a treatment?
If development proceeds, human clinical trials would take 3-5 years minimum before any health claims could be made. This research is a promising first step, but significant additional research is needed before Gnaphalium affine-based products reach the market.
Want to Apply This Research?
- Track weekly uric acid levels (if you have access to testing) or monthly gout attack frequency and severity. Record daily consumption of Gnaphalium affine products and note any changes in joint pain, swelling, or uric acid-related symptoms.
- If this plant becomes available as a food product or supplement, users could set a daily reminder to consume it consistently and log their intake in the app. They could also track their diet to identify other high-purine foods to avoid, creating a comprehensive uric acid management strategy.
- Create a 12-week tracking period to assess whether regular consumption correlates with reduced gout symptoms or lower uric acid levels. Use the app to generate reports showing trends over time, and share results with your healthcare provider to determine if this should be part of your long-term management plan.
This research describes laboratory findings only and has not been tested in humans. It should not be used to diagnose, treat, cure, or prevent any disease. People with high uric acid levels or gout should continue their prescribed medications and consult their healthcare provider before adding Gnaphalium affine or any new supplement to their diet. The compounds identified in this study may interact with medications or cause side effects in some individuals. This article is for educational purposes only and does not constitute medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.